Zoledronic acid hydrate - CAS 165800-06-6

Zoledronic acid hydrate (CAT: I0021706) is a bisphosphonate drug used for the treatment of bone diseases such as osteoporosis and bone metastases. It works by inhibiting the activity of osteoclasts, which are responsible for bone resorption. Zoledronic acid specifically targets the bone, where it is taken up by osteoclasts and inhibits their function, leading to a decrease in bone breakdown. This medication is typically administered intravenously and has a long duration of action, with a single dose providing therapeutic effects for several months. Zoledronic acid hydrate is an important therapeutic option in the management of various bone-related conditions.

Catalog Number: I002170

CAS Number: 165800-06-6

PubChem Substance ID:355039503

Molecular Formula: C5H12N2O8P2

Molecular Weight:290.1

Purity: ≥95%

Online inquiry

* For research use only. Not for human or veterinary use.

Synonym

Synonyms	P,P/’-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-phosphonic acid, monohydrate

Property

Molecular Formula:	C5H12N2O8P2
Molecular Weight	290.1
Target:	PKC
Solubility	water：7 mg/ml
Purity	≥95%
Storage	-20°C
MDL	MFCD08448695

Computed Descriptor

IUPAC Name	(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;hydrate
InChI	InChI=1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
InChIKey	FUXFIVRTGHOMSO-UHFFFAOYSA-N
SMILES	C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O